Fischer; Gina
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fischer; Gina.The latest application filed is for "morphine controlled release system".
- Fischer; Gina - Vaerlose DK
- Fischer; Gina - V.ae butted.rlose DK
- - Vaerløse DK
- Fischer; Gina - V{acute over .ae butted.
| Patent | Date |
|---|---|
| Morphine controlled release system Grant 9,884,029 - Fischer , et al. February 6, 2 | 2018-02-06 |
| Opioid polymer release system Grant 9,707,179 - Fischer , et al. July 18, 2 | 2017-07-18 |
| Polymer release system Grant 9,694,080 - Fischer , et al. July 4, 2 | 2017-07-04 |
| Morphine Controlled Release System App 20160361269 - Fischer; Gina ; et al. | 2016-12-15 |
| Morphine controlled release system Grant 9,375,428 - Fischer , et al. June 28, 2 | 2016-06-28 |
| Morphine Controlled Release System App 20150079150 - Fischer; Gina ; et al. | 2015-03-19 |
| Morphine Polymer Release System App 20150037417 - Fischer; Gina ; et al. | 2015-02-05 |
| Morphine controlled release system Grant 8,877,241 - Fischer , et al. November 4, 2 | 2014-11-04 |
| Morphine polymer release system Grant 8,808,745 - Fischer , et al. August 19, 2 | 2014-08-19 |
| Polymer Release System App 20140120164 - Fischer; Gina ; et al. | 2014-05-01 |
| Morphine Polymer Release System App 20140093569 - Fischer; Gina ; et al. | 2014-04-03 |
| Polymer release system Grant 8,617,605 - Fischer , et al. December 31, 2 | 2013-12-31 |
| Polymer release system Grant 08617605 - | 2013-12-31 |
| Morphine polymer release system Grant 8,609,143 - Fischer , et al. December 17, 2 | 2013-12-17 |
| Controlled release carvedilol compositions Grant 8,449,914 - Andersen , et al. May 28, 2 | 2013-05-28 |
| Swellable dosage form comprising gellan gum Grant 8,383,155 - Bar-Shalom , et al. February 26, 2 | 2013-02-26 |
| Swellable dosage form comprising gellan gum Grant 8,383,154 - Bar-Shalom , et al. February 26, 2 | 2013-02-26 |
| Swellable Dosage Form Comprising Gellan Gum App 20120039969 - Bar-Shalom; Daniel ; et al. | 2012-02-16 |
| Matrix Compositions For Controlled Delivery Of Drug Substances App 20100166866 - Fischer; Gina ; et al. | 2010-07-01 |
| Swellable Dosage Form Comprising Gellan Gum App 20080299199 - Bar-Shalom; Daniel ; et al. | 2008-12-04 |
| Controlled release carvedilol compositions App 20080268057 - Andersen; Christine ; et al. | 2008-10-30 |
| Morphine polymer release system App 20080254123 - Fischer; Gina ; et al. | 2008-10-16 |
| Polymer release system App 20080254122 - Fischer; Gina ; et al. | 2008-10-16 |
| Controlled release solid dispersions App 20080234352 - Fischer; Gina ; et al. | 2008-09-25 |
| Matrix compositions for controlled delivery of drug substances App 20070042044 - Fischer; Gina ; et al. | 2007-02-22 |
| Morphine controlled release system App 20070003617 - Fischer; Gina ; et al. | 2007-01-04 |
| Controlled release solid dispersions App 20050019399 - Fischer, Gina ; et al. | 2005-01-27 |
| Morphine polymer release system App 20040253310 - Fischer, Gina ; et al. | 2004-12-16 |
| Polymer release system App 20040234602 - Fischer, Gina ; et al. | 2004-11-25 |
| Controlled release carvedilol compositions App 20040151772 - Andersen, Christine ; et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 